| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/18/2005 | US20050181996 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 08/18/2005 | US20050181991 Use of artemin, a member of the GDNF ligand family |
| 08/18/2005 | US20050181980 Administering a formulation comprising an effective amount of:a sulfonylurea receptor 1 (SUR1) antagonist that reduces the activity of a NCCa-ATP channel; a pharmaceutically acceptable carrier |
| 08/18/2005 | US20050181973 comprising alternating hydrophobic and hydrophilic amino acids that are complementary and structurally compatible; three-dimensional scaffolds, encapsulating cells, used for cell cultures, tissue engineering and tissue repair |
| 08/18/2005 | US20050181972 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 08/18/2005 | US20050181508 Apparatus which utilizes alternating magnetic fields and biopolymer coated magnetically sensitive particles to transform membrane bound biological materials |
| 08/18/2005 | US20050181507 Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 08/18/2005 | US20050181506 Chromosome-based platforms |
| 08/18/2005 | US20050181505 Cosmetic repair using cartilage producing cells and medical implants coated therewith |
| 08/18/2005 | US20050181504 Using plug flow bioreactor system which mimics bone marrow microenvironment for propagation and maintenance of stromal cells |
| 08/18/2005 | US20050181503 inhibiting differentiation of progenitor or glial cells using G protein coupled receptor agonists and antagonists; treatment of neurdegenerative diseases; antitumor agents |
| 08/18/2005 | US20050181502 Multipotent adult stem cells and methods for isolation |
| 08/18/2005 | US20050181501 Anti-TECK antibodies and methods of use therefor |
| 08/18/2005 | US20050181495 Large scale productions of virus antigen |
| 08/18/2005 | US20050181484 Culturing porcine bone marrow stem cells in nutrient broth comprising interleukins and colony stimulating factor; propagating mast cell |
| 08/18/2005 | US20050181483 Method for producing monoclonal antibodies |
| 08/18/2005 | US20050181479 Expression vector comprising nucleotide sequences coding single sequence, multimeric immunoglobulin |
| 08/18/2005 | US20050181472 proteins from Pseudomonas, having butynol I esterase activity; nucleotides sequences codes; expression cassettes, vectors and genetic engineered microorganisms; used for stereospecific hydrolysis or transesterification of organic esters |
| 08/18/2005 | US20050181470 Laser cell purification system |
| 08/18/2005 | US20050181462 Mutant androgen receptor, cancer cells expressing the same, a method of producing them and use thereof |
| 08/18/2005 | US20050181459 Using peripheral blood monocytes to generate immunoglobulins specific to T cell epitopes; identifying immunoglobulin binding regions of preferential polypeptides |
| 08/18/2005 | US20050181450 Novel inositol 1,4,5-trisphosphate (IP3) receptor-binding protein and an IP3 indicator |
| 08/18/2005 | US20050181448 Biological products |
| 08/18/2005 | US20050181439 Streptococcus pneumoniae antigens and vaccines |
| 08/18/2005 | US20050181434 Glucuronyl C5-epimerase, DNA encoding the same and uses thereof |
| 08/18/2005 | US20050181422 Process for high throughput screening of CpG-based immuno-agonist/antagonist |
| 08/18/2005 | US20050181419 For detection of Mycobacterium tuberculosis infection |
| 08/18/2005 | US20050181414 Peptides associated with serine protease active site for use in identification of modulators for treatment of cell proliferative disorders |
| 08/18/2005 | US20050181413 Ovarian specific nucleic acid (OSNA) for use as diagnostic and prognostic tools in treatment and prevention of urogenital cancers; genetic vaccines |
| 08/18/2005 | US20050181391 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 08/18/2005 | US20050181016 Decullularized extracellular matrix of conditioned body tissues and uses thereof |
| 08/18/2005 | US20050180982 Assessing metastatic potential of carcinoma cells by contacting cells in tissue sample suspected of containing carcinoma with detectable indicator capable of binding to cad-11 or cad-11 mRNA and determining presence or absence of cad-11 expression in tissue; method of preventing or terminating pregnancy |
| 08/18/2005 | US20050180981 Human checkpoint kinase, hCDS1, compositions and methods |
| 08/18/2005 | US20050180980 Novel antibody recognizing a small subset of human hematopoietic cells |
| 08/18/2005 | US20050180977 Antibodies that bind to ET2, such as immunoglobulins that inhibit ET2 with high affinity and selectivity; can be used to treat angiogenesis-associated disorders. |
| 08/18/2005 | US20050180959 Kinases involved in the regulation of energy homeostasis |
| 08/18/2005 | US20050180958 Using plug flow bioreactor system which mimics bone marrow microenvironment for propagation and maintenance of stromal cells; transplanting undifferentiated hemopoietic stem cells into a recipient |
| 08/18/2005 | US20050180957 composition comprising a fibrinogen, a fibrinolysis inhibitor, an angiogenic growth factor, one or more encapsulated cells, a thrombin and a divalent salt; stimulating vascularization at a transplant site |
| 08/18/2005 | US20050180951 Fusion of autologous dendrtic cells with cancer cells that have the same class I MHC haplotype as said patient; and interleukin-12 |
| 08/18/2005 | DE19928210B4 Neuronales Zellmaterial und Verfahren zu dessen Herstellung Neural cell material and process for its preparation |
| 08/18/2005 | DE102004001225B3 Verfahren zur Herstellung dreidimensionaler trägerfreier Gewebestrukturen und nach diesem Verfahren hergestellte Gewebestrukturen A process for producing three-dimensional carrier-free tissue structures and tissue structures produced by this method |
| 08/18/2005 | CA2556161A1 Heparan-sulfate proteoglycan degrading enzymes for promotion of nerve regeneration |
| 08/18/2005 | CA2555411A1 A method and apparatus for orienting spherical cells |
| 08/18/2005 | CA2555332A1 Regulation of gene expression in plant cells |
| 08/18/2005 | CA2555306A1 Humanized antibody |
| 08/18/2005 | CA2555224A1 Watermelon varieties having altered sugar ratios |
| 08/18/2005 | CA2554784A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 08/18/2005 | CA2553040A1 Modified human four helical bundle polypeptides and their uses |
| 08/17/2005 | EP1564296A1 Stress tolerance and delayed senescence in plants |
| 08/17/2005 | EP1564293A1 Neural thread protein gene expression and detection of Alzheimer's disease |
| 08/17/2005 | EP1564285A1 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained |
| 08/17/2005 | EP1563084A2 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 08/17/2005 | EP1563073A2 Protein production methods and modified cells for use therein |
| 08/17/2005 | EP1563072A2 Dna sequences from tcd genomic region of photorhabdus luminescens |
| 08/17/2005 | EP1563061A1 Cultivation of hair inductive cells |
| 08/17/2005 | EP1563059A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 08/17/2005 | EP1563058A1 Hemangioblast progenitor cells |
| 08/17/2005 | EP1562987A2 Use of edg2 receptor in an animal model of heart failure |
| 08/17/2005 | EP1562969A2 Novel human cell surface protein with immunoglobulin folds, bgs-19 |
| 08/17/2005 | EP1562967A2 Adipocyte complement related protein zacrp14 |
| 08/17/2005 | EP1562636A2 Mesenchymal stem cells and methods of use thereof |
| 08/17/2005 | EP1562635A2 Modified dendritic cells |
| 08/17/2005 | EP1562598A2 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
| 08/17/2005 | EP1427830A4 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY |
| 08/17/2005 | EP1364197A4 High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation |
| 08/17/2005 | EP1345495A4 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 08/17/2005 | EP1287146B1 Cold sensitive mutant dna polymerases |
| 08/17/2005 | EP1109908B1 Methods for determining compounds for modulating the body weight |
| 08/17/2005 | EP1100878B8 Process for producing genetically modified cd34-negative adherently growing haematopoietic stem cells |
| 08/17/2005 | EP1088082B1 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch |
| 08/17/2005 | EP1073723B1 Ste20-related protein kinases |
| 08/17/2005 | EP1051500B1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 08/17/2005 | EP1007702B1 Method for increasing the gene expression of saccharose synthase |
| 08/17/2005 | EP0984983B1 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and a kinase domain |
| 08/17/2005 | EP0939804B1 NEUTROKINE alpha |
| 08/17/2005 | EP0846161B1 Release of intracellular material |
| 08/17/2005 | EP0837880B1 Enamel matrix related polypeptide |
| 08/17/2005 | EP0832189B1 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 08/17/2005 | EP0732930B1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 08/17/2005 | CN1656222A Antisense iap nucleobase oligomers and uses thereof |
| 08/17/2005 | CN1656218A Hydantoin racemase |
| 08/17/2005 | CN1656217A Modified phytases |
| 08/17/2005 | CN1656216A Tolerogenic antigen-presenting cells |
| 08/17/2005 | CN1656215A Process for producing cytotoxic lymphocyte |
| 08/17/2005 | CN1656214A Cytokine-free growth and maintenance of progenitor cells |
| 08/17/2005 | CN1656210A Cell culture system, apparatus for checking cultured cells and apparatus for culturing cells |
| 08/17/2005 | CN1656122A Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 08/17/2005 | CN1656118A Human 5-HT7 receptor promoter sequence |
| 08/17/2005 | CN1656114A Novel pancortin-pablo protein interactions and methods of use thereof |
| 08/17/2005 | CN1656068A Polypeptides and biosynthetic pathways |
| 08/17/2005 | CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 08/17/2005 | CN1655803A Methods of improving central nervous system functioning |
| 08/17/2005 | CN1655798A Mixed-cell gene therapy |
| 08/17/2005 | CN1655672A Method of preparing biological materials for cryopreservation using pre-chilled protectant |
| 08/17/2005 | CN1655671A Animal model for toxicology and dose prediction |
| 08/17/2005 | CN1655669A Nucleic acid constructs and methods for producing altered seed oil compositions |
| 08/17/2005 | CN1654661A Construction and expression of recombinant human trypsinogen 2 expression vector, preparation and application of its monoclonal antibody |
| 08/17/2005 | CN1654657A Novel streptococcus antigens |
| 08/17/2005 | CN1654636A Method for producing sex controllable in vitro embryo of buffalo |
| 08/17/2005 | CN1654635A Vitrification freezing, simple defreezing and direct implanting method for embryo |